A Prospective, Global Hip Dysplasia Registry with Follow-up to Skeletal Maturity: an Analysis of Risk Factors, Screening Practices and Treatment Outcomes

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Developmental dysplasia of the hip (DDH) is the most common hip condition affecting infants and children. DDH represents a spectrum of issues affecting the hip joint - a ball-and-socket joint. When the femoral head (the ball) is seated properly in the acetabulum (the socket), the hip is stable and can develop normally. However, when the femoral head is not well-seated, the hip can become unstable or dislocate. This instability or dislocation of the femoral head prevents the hip joint from developing normally during infancy and early childhood. If left undetected or untreated, it can lead to debilitating complications later in life. Development of a comprehensive, prospective international registry for all infants and children with DDH will provide the potential to impact all infants born, not only in British Columbia, but around the world. The purpose of this initiative is to identify best practices and standardize treatment and management strategies in order to optimize clinical and functional outcomes for patients with DDH. This registry includes targeted specific outcomes that will be investigated, in addition to the general collection of data on all patients diagnosed with any form of DDH up to the age of 10 years.

Eligibility
Participation Requirements
Sex: All
Minimum Age: Newborn
Maximum Age: 10
Healthy Volunteers: f
View:

• Between the ages of 0 and 10 years at time of initial diagnosis

• Referred for DDH screening due to specific risk factors OR diagnosed with DDH

• Diagnosis confirmed with appropriate ultrasonographic or radiographic imaging

Locations
Other Locations
Canada
British Columbia Children's Hospital
RECRUITING
Vancouver
Contact Information
Primary
Emily K Schaeffer, PhD
emily.schaeffer@cw.bc.ca
6048752359
Backup
Ashley L Munoz, BSc
ashley.munoz@cw.bc.ca
6048752359
Time Frame
Start Date: 2016-09-01
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 5000
Treatments
Arm I: Prospective from diagnosis
Patients have been enrolled and followed since diagnosis will be placed into Arm I.
Arm II: Prior treatment at center
Patients who have received previous treatment and will continue to receive treatment at the participating center will be placed into Arm II.
Arm III: Prior treatment at outside center
Patients who have received previous treatment at an outside center but are continuing treatment at a participating center will be placed into Arm III.
Authors
Emily K Schaeffer, Kishore Mulpuri
Related Therapeutic Areas
Sponsors
Leads: University of British Columbia

This content was sourced from clinicaltrials.gov